Refining Localized Prostate Cancer Management: Concepts and Controversies, An Issue of Urologic Clinics of North America
- 1 Edición, Volumen 53-1 - 25 de noviembre de 2025
- Última edición
- Editores: Hanan Goldberg, Gennady Bratslavsky
- Idioma: Inglés
In this issue of Urologic Clinics of North America, guest editors Drs. Hanan Goldberg and Gennady Bratslavsky bring their considerable expertise to the topic of Current Managemen… Leer más
Descripción
Descripción
In this issue of Urologic Clinics of North America, guest editors Drs. Hanan Goldberg and Gennady Bratslavsky bring their considerable expertise to the topic of Current Management of Localized Prostate Cancer. Top experts explore recent, significant investigation and research into various aspects of the assessment and management of clinically localized disease, which has led to novel findings and ideas regarding diagnostic, imaging, pathological, genetic, and therapeutic interventions for prostate cancer.
Puntos claves
Puntos claves
- Contains 14 relevant, practice-oriented topics, including prostate cancer biomarkers; advances in prostate biopsy; the role of genetic testing in localized prostate cancer; current surgical treatment of prostate cancer; current and upcoming trials in localized prostate cancer; and much more
- Provides in-depth clinical reviews on current management of localized prostate cancer, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
De interès para
De interès para
Urology
Índice
Índice
Prostate Cancer Screening: Evolution, Challenges, and Future Directions
Molecular Biomarkers for Localized Prostate Cancer: Current Progress and Future Directions
Advances in Prostate Biopsy
Prostate Cancer Grading: An Update
The Role of Genetic Testing in Localized Prostate Cancer
Imaging of Clinically Localized Prostate Cancer
Should Gleason 6 Still Be Considered Cancer? A Narrative Review of its Biology and Clinical Course, with Implications for Guideline Recommendations and Practice Implementation
Gleason Grade Group 1 Prostate Cancer: Arguments for and Against a Cancer Designation
Active Surveillance for Prostate Cancer
Focal Therapies for Localized Prostate Cancer
Current Surgical Treatment of Prostate Cancer
Role of Pelvic Lymph Node Dissection in the Surgical Treatment of Clinically Localized Prostate Cancer
Radiation Therapy for Prostate Cancer
Current and Upcoming Trials in Localized Prostate Cancer
Molecular Biomarkers for Localized Prostate Cancer: Current Progress and Future Directions
Advances in Prostate Biopsy
Prostate Cancer Grading: An Update
The Role of Genetic Testing in Localized Prostate Cancer
Imaging of Clinically Localized Prostate Cancer
Should Gleason 6 Still Be Considered Cancer? A Narrative Review of its Biology and Clinical Course, with Implications for Guideline Recommendations and Practice Implementation
Gleason Grade Group 1 Prostate Cancer: Arguments for and Against a Cancer Designation
Active Surveillance for Prostate Cancer
Focal Therapies for Localized Prostate Cancer
Current Surgical Treatment of Prostate Cancer
Role of Pelvic Lymph Node Dissection in the Surgical Treatment of Clinically Localized Prostate Cancer
Radiation Therapy for Prostate Cancer
Current and Upcoming Trials in Localized Prostate Cancer
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 53-1
- Publicado: 25 de noviembre de 2025
- Idioma: Inglés
Sobre los editores
Sobre los editores
HG
Hanan Goldberg
Afiliaciones y experiencia
Assistant Professor, Department of Urology, SUNY Upstate Medical University, Syracuse, New-York, Chief of Upstate Urology at Mohawk Valley Health System (MVHS), USAGB
Gennady Bratslavsky
Afiliaciones y experiencia
Chair, Department of Urology Phillip Capozzi M.D. Endowed Professor of Urology SUNY Upstate Medical University, Syracuse, NY, USA